Department of Industrial Engineering, University of Salerno, Fisciano, SA, Italy.
Department of Biology, Geology and Environmental Science, University of Bologna, Bologna, BO, Italy.
Biotechnol Bioeng. 2019 Jul;116(7):1777-1794. doi: 10.1002/bit.26975. Epub 2019 Apr 8.
Poly-lactic-co-glycolic acid (PLGA) microcarriers (0.8 ± 0.2 μm) have been fabricated with a load of 20 μg/g by an emulsion-based-proprietary technology to sustained deliver human bone morphogenetic protein 2 (hBMP2), a growth factor largely used for osteogenic induction. hBMP2 release profile, measured in vitro, showed a moderate "burst" release of 20% of the load in first 3 days, followed by a sustained release of 3% of the load along the following 21 days. PLGA microbeads loaded with fluorescent marker (8 mg/g ) and hydroxyapatite (30 mg/g ) were also fabricated and successfully dispersed within three-dimensional (3D) alginate scaffold (Ca-alginate 2% wt/wt) in a range between 50 and 200 mg/cm ; the presence of microcarriers within the scaffold induced a variation of its stiffness between 0.03 and 0.06 MPa; whereas the scaffold surface area was monitored always in the range of 190-200 m /g. Uniform microcarriers dispersion was obtained up to 200 mg/cm ; higher loading values in the 3D scaffold produced large aggregates. The release data and the surface area were, then, used to simulate by finite element modeling the hBMP2 mass transfer within the 3D hydrogel bioengineered with stem cells, in dynamic and static cultivations. The simulation was developed with COMSOL Multiphysics® giving a good representation of hBMP2 mass balances along microbeads (bulk eroded) and on cell surface (cell binding). hBMP2 degradation rate was also taken into account in the simulations. hBMP2 concentration of 20 ng/cm was set as a target because it has been described as the minimum effective value for stem cells stimulation versus the osteogenic phenotype. The sensitivity analysis suggested the best microbeads/cells ratio in the 3D microenvironment, along 21 days of cultivations in both static and dynamic cultivation (perfusion) conditions. The simulated formulation was so assembled experimentally using human mesenchymal stem cells and an improved scaffold stiffness up to 0.09 MPa (n = 3; p ≤ 0.01) was monitored after 21 days of cultivation; moreover a uniform extracellular matrix deposition within the 3D system was detected by Von Kossa staining, especially in dynamic conditions. The results indicated that the described tool can be useful for the design of 3D bioengineered microarchitecture by quantitative understanding.
聚乳酸-共-羟基乙酸(PLGA)微球(0.8±0.2μm)已通过基于乳液的专利技术制造,载药量为 20μg/g,以持续输送人骨形态发生蛋白 2(hBMP2),该生长因子广泛用于成骨诱导。在体外测量的 hBMP2 释放曲线显示,在最初的 3 天内,载药量的 20%会有适度的“爆发”释放,随后在接下来的 21 天内以 3%的载药量持续释放。还制备了载有荧光标记物(8mg/g)和羟基磷灰石(30mg/g)的 PLGA 微球,并成功分散在三维(3D)海藻酸钠支架(Ca-海藻酸钠 2%wt/wt)内,范围在 50 至 200mg/cm 之间;支架内微球的存在使支架的刚度在 0.03 至 0.06MPa 之间变化;而支架的表面积始终在 190-200m 2/g 之间。在 200mg/cm 范围内可获得均匀的微球分散;3D 支架中较高的载药量会产生较大的聚集体。然后,使用有限元建模根据释放数据和表面积来模拟在干细胞 3D 水凝胶中的 hBMP2 质量传递,在动态和静态培养中。使用 COMSOL Multiphysics® 进行模拟,很好地表示了微球(整体侵蚀)和细胞表面(细胞结合)上的 hBMP2 质量平衡。在模拟中还考虑了 hBMP2 的降解速率。将 20ng/cm 的 hBMP2 浓度设定为目标值,因为它已被描述为刺激干细胞向成骨表型转变的最小有效值。敏感性分析表明,在静态和动态培养(灌注)条件下 21 天的培养中,3D 微环境中微球/细胞的最佳比例。使用人骨髓间充质干细胞和提高的支架刚度(0.09MPa)实验组装了模拟配方(n=3;p≤0.01),在培养 21 天后进行监测;此外,通过 Von Kossa 染色在 3D 系统内检测到均匀的细胞外基质沉积,尤其是在动态条件下。结果表明,通过定量理解,该描述性工具可用于设计 3D 生物工程微结构。